Table 2.
Category | Subcategory | ICC (n = 174) |
---|---|---|
Intention of treatmenta | n | 174 (100) |
Palliative | 128 (73.6) | |
Downsizing | 33 (19) | |
Bridge to ablation | 8 (4.6) | |
Bridge to liver surgery | 3 (1.7) | |
Bridge to liver transplant | 2 (1.1) | |
Position of TARE in the continuum of care | n | 158 (90.8) |
First-line TARE | 62 (35.6) | |
First-line TARE plus concomitant systemic therapyc | 20 (11.5) | |
Second line TARE | 54 (31) | |
> 2nd line TARE | 22 (12.6) | |
Hepatic procedures prior to TARE | n | 174 (100) |
Yes | 49 (28.2) | |
No | 125 (71.8) | |
Type of hepatic proceduresb | n | 49 (100) |
Surgical (any) | 37 (75.5) | |
Ablation (any) | 8 (16.3) | |
TACE (any) | 2 (4.1) | |
Other embolotherapies (any) | 1 (2) | |
Abdominal radiotherapy (any) | 9 (18.4) | |
Systemic therapy after TARE | n | 174 (100) |
Yes | 84 (48.3) | |
Noc | 90 (51.7) | |
Number of systemic therapy lines after TARE | n | 83 (98.8) |
1 Line | 37 (44) | |
2–5 Lines | 31 (36.9) | |
6 or more lines | 15 (17.6) | |
Hepatic procedures after TARE | Yes | 29 (16.7) |
No | 145 (83.3) | |
Type of hepatic procedures after TAREd | n | 29 (100) |
Surgical (any) | 12 (41.4) | |
Ablation (any) | 5 (17.2) | |
TACE (any) | 1 (3.4) | |
Other embolotherapies (any) | 4 (13.8) | |
Abdominal radiotherapy (any) | 12 (41.4) | |
Not reported | 3 (10.3) |
N (%)
aIntention of TARE is for first treatment
bPatients can have multiple prior and post-TARE hepatic procedures
cConcomitant therapy is defined as any systemic therapy that starts within 56 days before or after TARE
dNo systemic therapy after TARE includes patients that were lost to follow-up or deceased before the first follow-up could be included (12 [10] for CIRT and 2 [3.7] for CIRT-FR)
ICC intrahepatic cholangiocarcinoma, TACE transarterial chemoembolization, TARE transarterial radioembolization
Categories where percentages (%) do not add up to 100 are due to missing information